AMRUTANJAN CMP: Rs 521.65. 20-DMA: Rs 511.16. RSI: 52.6. Pari Washington: 5.83L shares at Rs 500 = Rs 29.17 cr. DSP sold 5L at Rs 500.01.
Quick Answer
Amrutanjan Health Care share price is in focus after a series of block deal transactions involving three institutional investors. Pari Washington India Master Fund acquired 5.83 lakh shares (2.02% stake) at Rs 500 per share for Rs 29.17 crore. Simultaneously, Envision India Fund sold 2.13 lakh shares at Rs 523.58 for Rs 11.15 crore, and DSP Mutual Fund sold 5 lakh shares at Rs 500.01 per share for Rs 25 crore. DSP Mutual Fund held a 3.8% stake (10.98 lakh shares) as of June 2026.
Block Deal Summary: Who Bought and Who Sold Amrutanjan Shares?
Amrutanjan share price is witnessing multiple institutional trades on August 21, 2026. The net picture is a rotation between funds — Pari Washington is a new buyer while Envision and DSP are partial sellers.
| Party | Action | Shares | Price (Rs) | Value (Rs Cr) |
|---|---|---|---|---|
| Pari Washington India Master Fund | BUY | 5.83 lakh (2.02%) | 500.00 | 29.17 |
| Envision India Fund | SELL | 2.13 lakh | 523.58 | 11.15 |
| DSP Mutual Fund | SELL | 5.00 lakh | 500.01 | 25.00 |
Click Here – Get Free Investment Predictions
What Is Amrutanjan Health Care?
Amrutanjan Health Care is a consumer healthcare company best known for its Amrutanjan pain balm, a legacy brand with over 100 years of history in India. The company also makes OTC healthcare products including Comfy sanitary napkins and a range of cold relief products. Amrutanjan share price at Rs 521.65 is above its 20-DMA of Rs 511.16, with RSI at 52.6 indicating neutral momentum.
Screen Amrutanjan Health Care on Univest Screener
What the Block Deals Signal for Amrutanjan Share Price
The simultaneous buy by Pari Washington at Rs 500 and sell by DSP at Rs 500.01 suggests these were matched block transactions at approximately the same price. The Envision India Fund sold at Rs 523.58 — a higher price, likely an earlier or separate negotiated block. DSP Mutual Fund, which held 3.8% (10.98 lakh shares) as of June 2026, has reduced its position by 5 lakh shares, bringing its remaining holding to approximately 5.98 lakh shares. This institutional rotation is broadly neutral for Amrutanjan’s share price direction.
Download the Univest iOS App or Univest Android App to track Amrutanjan Health Care share price and institutional holding changes.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Amrutanjan Health Care share price in focus today?
Ans. Amrutanjan Health Care share price is in focus after multiple block deals: Pari Washington India Master Fund bought 5.83 lakh shares (2.02%) at Rs 500 for Rs 29.17 crore, while Envision India Fund sold 2.13 lakh shares at Rs 523.58 and DSP Mutual Fund sold 5 lakh shares at Rs 500.01.
Who bought Amrutanjan shares today?
Ans. Pari Washington India Master Fund, managed by Pari Washington Company, acquired 5.83 lakh shares representing a 2.02% stake in Amrutanjan Health Care at Rs 500 per share for Rs 29.17 crore on August 21, 2026.
Did DSP Mutual Fund sell Amrutanjan shares?
Ans. Yes. DSP Mutual Fund sold 5 lakh shares in Amrutanjan Health Care at Rs 500.01 per share for Rs 25 crore. DSP held a 3.8% stake (10.98 lakh shares) as of June 2026. After this sale, its remaining holding would be approximately 5.98 lakh shares.
What is Amrutanjan Health Care share price today?
Ans. Amrutanjan Health Care closed at Rs 521.65 on August 20, 2026, above its 20-DMA of Rs 511.16, with RSI at 52.6 (neutral). The block deal prices of Rs 500-523 represent a modest discount to market.
What products does Amrutanjan make?
Ans. Amrutanjan Health Care makes consumer healthcare products including the iconic Amrutanjan pain balm (a 100-year-old brand), Comfy sanitary napkins, and cold relief products. The company operates in the OTC healthcare segment targeting everyday consumer health needs.
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.